SU2C-SARC032: A phase II randomized controlled trial of neoadjuvant pembrolizumab with radiotherapy and adjuvant pembrolizumab for high-risk soft tissue sarcoma Meeting Abstract
| Authors: | Mowery, Y. M.; Ballman, K. V.; Riedel, R. F.; Brigman, B. E.; Attia, S.; Meyer, C. F.; Schuetze, S.; Burgess, M. A.; Chmielowski, B.; Dickson, M. A.; Hartner, L. P.; Milhem, M. M.; Tinoco, G.; Van Tine, B. A.; Wagner, A. J.; Reinke, D. K.; Kirsch, D. G. |
| Abstract Title: | SU2C-SARC032: A phase II randomized controlled trial of neoadjuvant pembrolizumab with radiotherapy and adjuvant pembrolizumab for high-risk soft tissue sarcoma |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 597s |
| Language: | English |
| ACCESSION: | WOS:000442916008049 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.TPS11588 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS11588 -- Source: Wos |
